Skip to main content

Day: April 28, 2021

Meridian Simplifies Workflows for POC Molecular Tests with a New Lyo-Ready™ LAMP Mix

CINCINNATI, April 28, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of the Lyo-Ready™ DNA LAMP Mix, specifically designed for accelerating the development of ambient temperature-stable loop-mediated isothermal amplification (LAMP) assays. The Lyo-Ready™ DNA LAMP Mix is formulated for rapid, robust, and sensitive DNA amplification through nucleic acid strand displacement. The COVID-19 pandemic has highlighted the benefit of point-of-care molecular diagnostic testing. LAMP assays are perfectly suited for point-of-care or portable testing because they are performed at one single temperature which reduces the cost and complexity of the device without the requirement of a thermocycler. Additionally, to further support...

Continue reading

Marie Brizard Wine & Spirits: 2020 Net Results

Charenton-le-Pont, April 28th, 2021 2020 Net Results         > Turnaround of Group profitability with an EBITDA(*)of €10.6m, including positive one-off effects of €3.7m related to the Covid Crisis on temporary ethyl alcohol bulk sales in Lithuania and            to the impact of the change of distribution model in the United States in the first half of 2020                    > Significant improvement in Net Result from continuing activities : losses divided by more than 5         > Net financial debt reduced to €43.6m (*) EBITDA = EBIT – provisions for current assets – depreciation – pension liabilitiesNB: All sales growth figures mentioned in this press release are at constant exchange rates and on a like-for-like basis, unless otherwise stated. Marie Brizard Wine & Spirits (Euronext : MBWS) today announces its consolidated results...

Continue reading

ServisFirst Bancshares, Inc. Named to 2021 KBW Bank Honor Roll: Guardians of Growth in Uncertain Times

BIRMINGHAM, Ala., April 28, 2021 (GLOBE NEWSWIRE) — ServisFirst Bancshares, Inc. (NASDAQ: SFBS) announced today that it has been added to the 2021 KBW Bank Honor Roll: Guardians of Growth in Uncertain Times, which highlights banks that consistently deliver exceptional growth per share over the past 10 years. This is the sixth year ServisFirst Bank has been named to this list of banking institutions. Only sixteen out of nearly 365 evaluated banking institutions nationwide qualified for this year’s list. To be eligible for the KBW Bank Honor Roll, banks with more than $500 million in total assets must have reported consecutive increases in annual earnings per share over the past decade. For more information about ServisFirst Bank, please contact Krista Conlin at 205-937-3777. To learn more about ServisFirst Bank, please visit us...

Continue reading

Annual General Meeting 2021

COMPANY ANNOUNCEMENT NO. 22/2021 – 28 APRIL 2021 On Wednesday, 28 April 2021 at 5 pm Royal Unibrew A/S held its fully virtual Annual General Meeting. 1.        Report on the Company’s activities during the year The Board of Directors’ report was noted. 2.        Presentation of the audited Annual Report for 2020 for adoption The Company’s Annual Report for 2020 was adopted by the Annual General Meeting. 3.        Resolution to discharge the Board of Directors and the Executive Board from liability The General Meeting adopted the resolution to discharge the Board of Directors and the Executive Board from liability. 4.        Proposed distribution of profit for the year, including resolution on the amount of dividend The General Meeting adopted the Board of Directors’ proposal to pay out a dividend of DKK 13,50 per share of nominally...

Continue reading

Islandsbanki hf.: Publication of 1Q2021 results

  Íslandsbanki will publish its first quarter 2021 financial results after market close on 5 May 2021. Earnings conference call and webcast on Wednesday 5 May at 16.00 Reykjavík/GMT, 1700hrs London/BST, 1800hrs CET The Bank will host a virtual meeting in English for investors and market participants on Wednesday 5 May at 16.00 GMT. Birna Einarsdóttir, CEO, and Jón Guðni Ómarsson, CFO, will give an overview of the first quarter financial results and operational highlights. Participant registration is accessible here. A recording will be available after the meeting on the Investor Relations website. To participate in the webcast via telephone and in order to be able to ask questions please use the following dial-in details: Iceland: +354 800 74 37 Denmark: +45 3 544 55 77 Sweden: +46 8 566 42 651 Norway: +47 235 00 243 United Kingdom:...

Continue reading

Jennifer Chronis named head of Verizon Public Sector

Chronis will lead the team dedicated to delivering the critical technologies and solutions Verizon Public Sector customers require to serve their constituents and achieve their missions WASHINGTON, April 28, 2021 (GLOBE NEWSWIRE) — Jennifer Chronis has been named as the senior vice president of Verizon Public Sector, effective today. She will lead the team of professionals dedicated to partnering with Verizon’s federal, state, local, education and public safety customers to deliver technology solutions and services, including Verizon Frontline, the network and solution platform for first responders, that help them achieve their missions. Chronis has spent her career in service of the public sector, and will carry on Verizon’s decades-long commitment to the unique technology needs of public sector customers. She served for more...

Continue reading

Awilco Drilling PLC: Annual Report 2020

Please find enclosed the Annual Report and Financial Statements 2020 for Awilco Drilling PLC. Aberdeen, 28 April 2021 For further information please contact: Eric Jacobs, Interim CEOPhone: +44 1224 737900 Cathrine Haavind, IR ManagerPhone: +47 93 42 84 64Email: ch@awilcodrilling.com This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.AttachmentAWDR Annual Report 2020 signed

Continue reading

Solutions 30 : +19% GROWTH IN 2021 Q1 REVENUE

Strong sales momentum and very positive market trends Outlook for double-digit, profitable growth confirmedSolutions 30 SE, the European leader in solutions for new technologies, today disclosed its revenue for the first quarter of 2021.In millions of euros Q1 2021 Q1 2020 % changeTotal 225.2 189.3 +19.0%From France 142.1 116.4 +22.1%From Benelux 37.0 34.8 +6.3%From other countries 46.1 38.1 +21.0%Data for the Q1 2020 have been restated to consolidate Worldlink as of January 1, 2020. Solid growth trend continues Consolidated revenue Solutions 30’s consolidated revenue for the first quarter of 2021 amounted to €225.2 million, up +19.0% (+15.4% organic growth) compared to the same period in 2020. The group’s maintenance business, which is recurrent in nature, represents 58% of the group’s revenue. As in 2020, positive...

Continue reading

Solutions 30 : 2020 EARNINGS REPORT

Operational performance remains extremely resilientRevenue grew by 18% to €819.3 million EBITDA margin increases to 13.0% Net cash position of €59.2 millionAccelerating the group’s transformationFoundations reinforced to consolidate growthLong-term outlook confirmedPotential for growth underpinned by the digital transformation and the energy transition, and bolstered by European recovery plansSolutions 30 SE today announces its consolidated earnings for the financial year ended December 31. The Supervisory Board of Solutions 30, meeting on April 27, examined and approved the financial results for 2020, as approved by the Group Management Board. These results are still being audited. The complete consolidated financial statements, including the notes, will be made available as soon as possible. The financial presentation...

Continue reading

Provectus Biopharmaceuticals Announces Acceptance of PV-10® Immunotherapy Abstracts at American Society of Clinical Oncology (ASCO) 2021 Annual Meeting

— Intralesional (aka intratumoral) PV-10 administration for treatment of hepatic metastatic neuroendocrine tumors (NCT02693067) — Systemic administration of PV-10 for treatment of solid tumor cancers KNOXVILLE, TN, April 28, 2021 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced that two abstracts about data from clinical and preclinical study of investigational cancer immunotherapy PV-10 (rose bengal disodium) were accepted for the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, which will be held June 4-8 online. Abstract #1:Title: Phase I study of autolytic immunotherapy of metastatic neuroendocrine tumors using intralesional rose bengal disodium Session Title: Poster Session: Gastrointestinal Cancer – Gastroesophageal, Pancreatic, and Hepatobiliary Abstract number for publication: 4115This clinical...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.